Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- nirmatrelvir / ritonavir
- thiotepa
Interactions between your drugs
thiotepa ritonavir
Applies to: thiotepa, nirmatrelvir / ritonavir
Talk to your doctor before using ritonavir together with thiotepa. Combining these medications may alter the blood levels thiotepa which may make it less effective in treating your cancer. You may also have increased side effects such as nausea, vomiting, mouth ulcers, skin conditions, and low blood cell counts, which can make you more likely to develop anemia, bleeding problems, and infections. Your doctor may already be aware of the risks but has determined that this is the best course of treatment for you and has taken appropriate precautions and is monitoring you more closely. Contact your doctor if you experience potential signs and symptoms of these conditions such as paleness of skin, fatigue, dizziness, fainting, unusual bleeding or bruising, fever, chills, sore throat, body aches, or other flu-like symptoms. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food/lifestyle interactions
ritonavir food/lifestyle
Applies to: nirmatrelvir / ritonavir
Ritonavir should be taken with food to lessen gastrointestinal side effects. It is important that you take this medication exactly as prescribed by your doctor. Do not change your treatment or stop treatment without first talking to your doctor.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Paxlovid
PAXLOVID (nirmatrelvir with ritonavir) is an antiviral medication used to treat COVID-19. Includes ...
Actemra
Actemra is used to treat COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Tyenne
Tyenne is approved to treat adults with moderately to severely active rheumatoid arthritis, Giant ...
Olumiant
Olumiant is used to treat rheumatoid arthritis, alopecia areata (hair loss), and COVID-19. Includes ...
Kineret
Kineret is used to treat the symptoms of moderate to severe rheumatoid arthritis ...
Anakinra
Anakinra is used for COVID-19, cryopyrin-associated periodic syndromes, interleukin-1 receptor ...
Baricitinib
Baricitinib (brand name Olumiant) is used to treat rheumatoid arthritis, alopecia areata (hair ...
Molnupiravir
Molnupiravir is an experimental medicine being studied for the treatment of mild-to-moderate ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.